{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:09:51Z","timestamp":1789567791405,"version":"build-2803163510"},"reference-count":220,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease that imposes a substantial lifelong burden on patients, particularly as it commonly develops during adolescence or early adulthood. Despite major advances in pharmacological management, including the introduction of biologic agents and small-molecule therapies, considerable interindividual variability in therapeutic response remains a major clinical challenge. Emerging evidence in pharmacomicrobiomics indicates that the gut microbiota contributes to this variability through bidirectional interactions with drugs. These interactions involve direct microbial biotransformation of drugs, modulation of host metabolic pathways and transport systems, and pharmacodynamic effects mediated by microbiota that collectively influence drug efficacy, safety, and therapeutic outcomes. Strategies aimed at restoring microbial homeostasis, including dietary interventions, probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation, have therefore attracted increasing attention as adjunctive approaches in UC. Among these, probiotics are the most extensively investigated, and selected formulations have demonstrated clinical benefit in inducing and maintaining remission of UC. However, while their direct therapeutic effects have been widely reviewed, considerably less attention has been devoted to understanding how probiotics interact with conventional UC therapies and whether they modify treatment efficacy through pharmacokinetic, pharmacodynamic, or microbiota-mediated mechanisms. This review provides an up-to-date overview of probiotic-drug interactions in UC, with particular emphasis on microbiota- and metabolite-mediated mechanisms that may influence therapeutic efficacy and contribute to interindividual variability in treatment response. Finally, we discuss current concepts for the rational use of probiotics as adjuncts to UC pharmacotherapy and highlight key knowledge gaps and future research directions in this rapidly evolving field. A better understanding of these interactions may ultimately support microbiota-informed therapeutic strategies aimed at optimizing treatment outcomes in UC.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1944134","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:44:35Z","timestamp":1789566275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective"],"prefix":"10.3389","volume":"17","author":[{"given":"Jana","family":"\u0160tofilov\u00e1","sequence":"first","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Benetinov\u00e1","sequence":"additional","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Bertkov\u00e1","sequence":"additional","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Hanzelov\u00e1","sequence":"additional","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kaml\u00e1rov\u00e1","sequence":"additional","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kvakov\u00e1","sequence":"additional","affiliation":[{"name":"Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, P.J. Safarik University in Kosice","place":["Kosice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/flgastro-2018-101057","article-title":"Antibiotics and probiotics in inflammatory bowel disease: When to use them?","volume":"11","author":"Abraham","year":"2020","journal-title":"Frontline Gastroenterol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.aninu.2021.11.005","article-title":"Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation","volume":"8","author":"Akhtar","year":"2021","journal-title":"Anim. Nutr."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2604867","DOI":"10.1080\/19490976.2025.2604867","article-title":"Microbes and medicines: interrelationships between pharmaceuticals and the gut microbiome","volume":"18","author":"Al-Btoosh","year":"2026","journal-title":"Gut Microbes"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"i2393","DOI":"10.1093\/ecco-jcc\/jjae190.1503","article-title":"P1329 longitudinal study of the gut microbiome in patients with ulcerative colitis on biological treatment with vedolizumab","volume":"19","author":"Alonso","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2016-312450","article-title":"Microbiota: Relevant player in thiopurine metabolisation?","volume":"66","author":"Atreya","year":"2017","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12967-025-07651-4","article-title":"Time-dependent Lactiplantibacillus plantarum (LP) AS21 intervention enhances mesalazine efficacy by modulating gut microbiota and host immunometabolic responses in DSS-induced colitis","volume":"24","author":"Bacha","year":"2026","journal-title":"J. Transl. Med."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5217\/ir.2025.00061","article-title":"Preventive and therapeutic effects of co-administration of Bacteroides thetaiotaomicron and infliximab on dextran sodium sulfate-induced colitis in mice","volume":"24","author":"Badi","year":"2025","journal-title":"Intest. Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-022-03303-z","article-title":"FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17\/regulatory T-cell balance","volume":"20","author":"Baek","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1456053","DOI":"10.3389\/fmolb.2024.1456053","article-title":"Investigating the effects of combined treatment of mesalazine with Lactobacillus casei in the experimental model of ulcerative colitis","volume":"11","author":"Bahrami","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/microorganisms14051082","article-title":"Emerging role of gut microbiota in modulating response to therapies in IBD","volume":"14","author":"Bartocci","year":"2026","journal-title":"Microorganisms"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1107976","DOI":"10.3389\/fmicb.2023.1107976","article-title":"Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease","volume":"14","author":"Becker","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12915-026-02569-9","article-title":"6-mercaptopurine and tofacitinib alter microbial protein expression but not composition in fecal microbiota incubations from Crohn\u2019s disease patients","volume":"24","author":"Becker","year":"2026","journal-title":"BMC Biol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40262-018-0676-z","article-title":"Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of ulcerative colitis","volume":"58","author":"Berends","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn\u2019s disease","volume":"27","author":"Bjarnason","year":"2019","journal-title":"Inflammopharmacology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ibd\/izad126","article-title":"Prediction of response to systemic corticosteroids in active UC by microbial composition\u2014a prospective multicenter study","volume":"30","author":"Blesl","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/microorganisms9061122","article-title":"Bile salt hydrolases: at the crossroads of microbiota and human health","volume":"9","author":"Bourgin","year":"2021","journal-title":"Microorganisms"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1565082","DOI":"10.3389\/fcimb.2025.1565082","article-title":"Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment","volume":"15","author":"Bu","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/apt.16096","article-title":"Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease","volume":"52","author":"Caenepeel","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/ijms27021079","article-title":"Antioxidant and anti-inflammatory activities of probiotic strains","volume":"27","author":"Caliman-Sturdza","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e03227-20","DOI":"10.1128\/mBio.03227-20","article-title":"5-Aminosalicylic acid ameliorates colitis and checks dysbiotic Escherichia coli expansion by activating PPAR-\u03b3 signaling in the intestinal epithelium","volume":"12","author":"Cevallos","year":"2021","journal-title":"MBio"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.20517\/evcna.2026.09","article-title":"Engineered bacterial extracellular vesicles as next-generation precision postbiotics: strategies, challenges and prospects","volume":"7","author":"Chen","year":"","journal-title":"Extracell. Vesicles Circ. Nucleic Acids"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2611546","DOI":"10.1080\/19490976.2025.2611546","article-title":"Akkermansia muciniphila-derived extracellular vesicles alleviate colitis-related cognitive impairment via tryptophan metabolic reprogramming of the gut\u2013brain axis","volume":"18","author":"Chen","year":"","journal-title":"Gut Microbes"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.pep.2003.12.016","article-title":"Molecular cloning, overexpression, purification, and characterization of an aerobic FMN-dependent azoreductase from Enterococcus faecalis","volume":"34","author":"Chen","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"108327","DOI":"10.1016\/j.phrs.2026.108327","article-title":"Duality of Bacteroides cross-feeding networks in health and disease","volume":"230","author":"Chen","year":"","journal-title":"Pharmacol. Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1779143","DOI":"10.3389\/fmicb.2026.1779143","article-title":"The outcome of infliximab induction in patients with severe ulcerative colitis may be related to intestinal microbiota","volume":"17","author":"Chen","year":"","journal-title":"Front. Microbiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","article-title":"Probiotic mixture VSL#3: an overview of basic and clinical studies in chronic diseases","volume":"8","author":"Cheng","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2297860","DOI":"10.1080\/19490976.2023.2297860","article-title":"Multi-omic approaches for host-microbiome data integration","volume":"16","author":"Chetty","year":"2024","journal-title":"Gut Microbes"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/apt.70826","article-title":"Review article: the impact of the gut microbiome on ulcerative colitis pharmacotherapy","volume":"64","author":"Collins","year":"2026","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.apsb.2019.12.001","article-title":"The gut microbiome: an orchestrator of xenobiotic metabolism","volume":"10","author":"Collins","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2300449","DOI":"10.1002\/adtp.202300449","article-title":"Bacterial influence on pharmacokinetics of tacrolimus and sulfasalazine through regulation of host metabolism","volume":"7","author":"Cooper","year":"2024","journal-title":"Adv. Ther."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/1744666X.2023.2292768","article-title":"Management and treatment optimization of patients with mild to moderate ulcerative colitis","volume":"20","author":"D\u2019Amico","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"8833","DOI":"10.48101\/ujms.v127.8833","article-title":"Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records","volume":"127","author":"Dahlgren","year":"2022","journal-title":"Ups. J. Med. Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12951-026-04421-2","article-title":"Layer-by-layer engineered outer membrane vesicles enable oral upadacitinib delivery for inflammation control and fibrosis attenuation in ulcerative colitis","volume":"24","author":"Dai","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.3390\/jcm14238273","article-title":"The role of cyclosporine in the treatment of severe ulcerative colitis in the pediatric population: a narrative review exploring known strategies and new possibilities","volume":"14","author":"Dancewicz","year":"2025","journal-title":"J. Clin. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1280.e1","DOI":"10.1016\/j.cgh.2020.01.023","article-title":"Positioning therapies in ulcerative colitis","volume":"18","author":"Danese","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.7326\/M13-2403","article-title":"Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis","volume":"160","author":"Danese","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"112568","DOI":"10.1016\/j.isci.2025.112568","article-title":"Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis","volume":"28","author":"Dang","year":"2025","journal-title":"iScience"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1608110","DOI":"10.3389\/fphar.2025.1608110","article-title":"Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response","volume":"16","author":"Dani\u0107","year":"2025","journal-title":"Front. Pharmacol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40168-023-01578-y","article-title":"Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1","volume":"11","author":"Degraeve","year":"2023","journal-title":"Microbiome"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12964-025-02520-5","article-title":"Epigenetic orchestrator and drug enhancer: dual roles of butyrate in regulating post-translational modification and optimizing therapeutic delivery","volume":"23","author":"Deng","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/cells11162617","article-title":"A multi-strain probiotic formulation improves intestinal barrier function by the modulation of tight and adherent junction proteins","volume":"11","author":"Di Vito","year":"2022","journal-title":"Cells"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41575-026-01195-8","article-title":"The microbiome regulates host metabolic health and diseases through microbial enzymes","volume":"23","author":"Ding","year":"2026","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s13238-018-0547-2","article-title":"Pharmacomicrobiomics: a novel route towards personalized medicine?","volume":"9","author":"Doestzada","year":"2018","journal-title":"Protein Cell"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e02120-17","DOI":"10.1128\/mBio.02120-17","article-title":"Fecal microbiota signatures are associated with response to ustekinumab therapy among Crohn\u2019s disease patients","volume":"9","author":"Doherty","year":"2018","journal-title":"mBio"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/pharmaceutics16010130","article-title":"The mechanism and potential therapeutic effects of cyclosporin, cyclophilin, probiotics and syndecan-1 in an animal model of inflammatory bowel disease","volume":"16","author":"Dosh","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"117927","DOI":"10.1016\/j.lfs.2020.117927","article-title":"The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2\/Ho-1 pathway","volume":"256","author":"El-Baz","year":"2020","journal-title":"Life Sci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1713426","DOI":"10.3389\/fimmu.2025.1713426","article-title":"Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives\u2014a comprehensive review","volume":"16","author":"El-Saadony","year":"2026","journal-title":"Front. Immunol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"106845","DOI":"10.1016\/j.ejps.2024.106845","article-title":"Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: implications for colonic drug delivery and inflammatory bowel disease","volume":"200","author":"Favaron","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"107365","DOI":"10.1016\/j.ejps.2025.107365","article-title":"Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease","volume":"216","author":"Favaron","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/jcm11092302","article-title":"An update on current pharmacotherapeutic options for the treatment of ulcerative colitis","volume":"11","author":"Ferretti","year":"2022","journal-title":"J. Clin. Med."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.cgh.2025.06.009","article-title":"Appropriate use and complications of corticosteroids in inflammatory bowel disease: a comprehensive review","volume":"23","author":"Feuerstein","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0199322","DOI":"10.1128\/mBio.01993-22","article-title":"Microbial metabolites orchestrate a distinct multi-tiered regulatory network in the intestinal epithelium that directs P-glycoprotein expression","volume":"13","author":"Foley","year":"2022","journal-title":"mBio"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/pathogens10020211","article-title":"Microbiota and drug response in inflammatory bowel disease","volume":"10","author":"Franzin","year":"2021","journal-title":"Pathogens"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/nu14153212","article-title":"Bile salt hydrolase-competent probiotics in the management of IBD: unlocking the \u201cbile acid code\u201d","volume":"14","author":"Gadaleta","year":"2022","journal-title":"Nutrients"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1039\/d5fo04869a","article-title":"Tryptophan metabolites derived from Lactiplantibacillus plantarum Y42 regulate the AhR\/Nrf2\/NF-\u03baB axis to ameliorate colitis in mice","volume":"17","author":"Gao","year":"2026","journal-title":"Food Funct."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/microorganisms13051047","article-title":"Personalized microbiome modulation to improve clinical outcomes in pediatric inflammatory bowel disease: a multi-omics and interventional approach","volume":"13","author":"Goldi\u0219","year":"2025","journal-title":"Microorganisms"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/flgastro-2015-100681","article-title":"Monitoring thiopurine metabolites in inflammatory bowel disease","volume":"7","author":"Gonz\u00e1lez-Lama","year":"2016","journal-title":"Frontline Gastroenterol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/cpt.70066","article-title":"Pharmacomicrobiomics","volume":"118","author":"Gronich","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"126779","DOI":"10.1016\/j.ijpharm.2026.126779","article-title":"Single-cell probiotic encapsulation with a sandwich-structured nanocoating for intestinal-targeted delivery and inflammatory-responsive drug release","volume":"695","author":"Gu","year":"2026","journal-title":"Int. J. Pharm."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12964-024-01611-z","article-title":"The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum","volume":"22","author":"Guo","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1002\/iid3.1045","article-title":"Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis","volume":"11","author":"Guo","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ebiom.2019.05.009","article-title":"Bringing microbiome-drug interaction research into the clinic","volume":"44","author":"Guthrie","year":"2019","journal-title":"EBioMedicine"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"9640","DOI":"10.1038\/s41598-022-13753-6","article-title":"Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice","volume":"12","author":"Han","year":"2022","journal-title":"Sci. Rep."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2025.05.015","article-title":"An international consensus on appropriate management of corticosteroids in clinical trials in inflammatory bowel disease","volume":"169","author":"Han\u017eel","year":"2025","journal-title":"Gastroenterology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"777147","DOI":"10.3389\/fimmu.2021.777147","article-title":"Effect of extracellular vesicles derived from Lactobacillus plantarum Q7 on gut microbiota and ulcerative colitis in mice","volume":"12","author":"Hao","year":"2021","journal-title":"Front. Immunol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1089099","DOI":"10.3389\/fmed.2023.1089099","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front. Med."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.22037\/ghfbb.v18i2.3105","article-title":"Global prevalence and incidence of inflammatory bowel disease: a systematic review and meta-analysis of population-based studies","volume":"18","author":"Heydari","year":"2025","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12866-024-03705-7","article-title":"Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects","volume":"24","author":"Hu","year":"2024","journal-title":"BMC Microbiol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"CD007443","DOI":"10.1002\/14651858.CD007443.pub3","article-title":"Probiotics for maintenance of remission in ulcerative colitis","volume":"2020","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.3390\/jcm14186574","article-title":"Efficacy of biologics in patients with ulcerative colitis exhibiting non-response or insufficient response to cytapheresis","volume":"14","author":"Iizuka","year":"2025","journal-title":"J. Clin. Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/microorganisms13040739","article-title":"The effects of different probiotic administration on dexamethasone-associated metabolic effects","volume":"13","author":"Inceu","year":"2025","journal-title":"Microorganisms"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"15111","DOI":"10.3390\/ijms242015111","article-title":"The effects of probiotic Bacillus spores on dexamethasone-treated rats","volume":"24","author":"Inceu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00253-025-13424-2","article-title":"Combination of probiotics enhancing butyrogenesis in colonic microbiota model of patients with ulcerative colitis","volume":"109","author":"Inokuma","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e35980","DOI":"10.1016\/j.heliyon.2024.e35980","article-title":"Next generation probiotics for human health: an emerging perspective","volume":"10","author":"Jan","year":"2024","journal-title":"Heliyon"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-025-02345-1","article-title":"Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies","volume":"11","author":"Jia","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e12736","DOI":"10.1002\/smll.202512736","article-title":"Programmable biohybrid probiotics with long-term storage stability for enhanced intestinal microbiota regulation and ulcerative colitis treatment","volume":"22","author":"Jiang","year":"2026","journal-title":"Small"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40168-015-0146-x","article-title":"Metatranscriptomic analysis of diverse microbial communities reveals core metabolic pathways and microbiome-specific functionality","volume":"4","author":"Jiang","year":"2016","journal-title":"Microbiome"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0090-9556(25)06497-9","article-title":"Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver","volume":"23","author":"J\u00f6nsson","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3389\/fphar.2020.01303","article-title":"Gut microbiome alters the activity of liver cytochromes P450 in mice with sex-dependent differences","volume":"11","author":"Jourov\u00e1","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor \u03baB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"156249","DOI":"10.1016\/j.prp.2025.156249","article-title":"From inflammation to carcinogenesis: distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC","volume":"275","author":"Kapadia","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/s41598-019-39401-0","article-title":"Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation","volume":"9","author":"Khare","year":"2019","journal-title":"Sci. Rep."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1124\/dmd.117.077222","article-title":"Effect of probiotics on pharmacokinetics of orally administered acetaminophen in mice","volume":"46","author":"Kim","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"e70320","DOI":"10.1111\/1541-4337.70320","article-title":"Probiotic development strategy centered on stability and regulatory considerations","volume":"25","author":"Kim","year":"2026","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"128384","DOI":"10.1016\/j.micres.2025.128384","article-title":"Microbiome based precision medicine through integrated multiomics and machine learning","volume":"303","author":"Kumar","year":"2026","journal-title":"Microbiol. Res."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"177176","DOI":"10.1016\/j.ejphar.2024.177176","article-title":"Impact of calcineurin inhibitors on gut microbiota: focus on tacrolimus with evidence from in vivo and clinical studies","volume":"987","author":"Kunasol","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e115175","DOI":"10.1371\/journal.pone.0115175","article-title":"Bacterial bile metabolising gene abundance in Crohn\u2019s, ulcerative colitis and type 2 diabetes metagenomes","volume":"9","author":"Labb\u00e9","year":"2014","journal-title":"PLoS One"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"879170","DOI":"10.3389\/fphar.2022.879170","article-title":"Gut microbiota metabolism of azathioprine: a new hallmark for personalized drug-targeted therapy of chronic inflammatory bowel disease","volume":"13","author":"Lazarevi\u0107","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40259-025-00739-9","article-title":"Bidirectional interplay between IBD therapies and the gut microbiota: a pharmacomicrobiomic approach to personalized treatment","volume":"39","author":"Lazarevi\u0107","year":"2025","journal-title":"BioDrugs"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/pharmaceutics16111431","article-title":"Drug interaction-informed approaches to inflammatory bowel disease management","volume":"16","author":"Lee","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3109\/00498254.2012.660508","article-title":"The influence of probiotic treatment on sulfasalazine metabolism in rat","volume":"42","author":"Lee","year":"2012","journal-title":"Xenobiotica"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1209613","DOI":"10.3389\/fnut.2023.1209613","article-title":"Modulation of immunity by tryptophan microbial metabolites","volume":"10","author":"Li","year":"","journal-title":"Front. Nutr."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2557979","DOI":"10.1080\/19490976.2025.2557979","article-title":"Tryptophan catabolites from microbiota ameliorate immune-mediated hepatitis through activating aryl hydrocarbon receptor of T cells","volume":"17","author":"Li","year":"2025","journal-title":"Gut Microbes"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"106235","DOI":"10.1016\/j.ejps.2022.106235","article-title":"Pharmacokinetic and gut microbiota analyses revealed the effect of Lactobacillus acidophilus on the metabolism of olsalazine in ulcerative colitis rats","volume":"175","author":"Li","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1112767","DOI":"10.3389\/fmicb.2023.1112767","article-title":"Long-term prednisone treatment causes fungal microbiota dysbiosis and alters the ecological interaction between gut mycobiome and bacteriome in rats","volume":"14","author":"Li","year":"","journal-title":"Front. Microbiol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1827426","DOI":"10.3389\/fimmu.2026.1827426","article-title":"Gut microbiota metabolites in inflammatory bowel disease: advances in mechanistic insights","volume":"17","author":"Liang","year":"2026","journal-title":"Front. Immunol."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"100","DOI":"10.31138\/mjr.31.1.100","article-title":"Basic mechanisms of JAK inhibition","volume":"31","author":"Lin","year":"2020","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"e01457","DOI":"10.1128\/spectrum.01457-23","article-title":"Gut microbiome and metabonomic profile predict early remission to anti-integrin therapy in patients with moderate to severe ulcerative colitis","volume":"11","author":"Liu","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fmicb.2017.00527","article-title":"Azathioprine, mercaptopurine, and 5-aminosalicylic acid affect the growth of IBD-associated Campylobacter species and other enteric microbes","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12986-025-01002-2","article-title":"Probiotics and inflammatory bowel disease: an umbrella meta-analysis of relapse, recurrence, and remission outcomes","volume":"22","author":"Liu","year":"2025","journal-title":"Nutr. Metab."},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04850-z","article-title":"Probiotic-based sequential delivery system for gut-brain co-therapy against inflammatory bowel disease-associated anxiety\/depression","author":"Liu","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"14201","DOI":"10.3389\/ti.2025.14201","article-title":"State of art of dose individualization to support tacrolimus drug monitoring: What\u2019s next?","volume":"38","author":"Lloberas","year":"2025","journal-title":"Transpl. Int."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1130820","DOI":"10.3389\/fcimb.2023.1130820","article-title":"Combination of Lactobacillus plantarum improves the effects of tacrolimus on colitis in a mouse model","volume":"13","author":"Lv","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref107","volume-title":"StatPearls","author":"Lynch","year":"2025"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.xcrm.2025.102426","article-title":"Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: outcome of a randomized controlled trial","volume":"6","author":"Lyu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"20220821","DOI":"10.1515\/biol-2022-0821","article-title":"Probiotics for inflammatory bowel disease: Is there sufficient evidence?","volume":"19","author":"Ma","year":"2024","journal-title":"Open Life Sci."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","article-title":"Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition","volume":"10","author":"Magnusson","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"e76585","DOI":"10.1002\/advs.76585","article-title":"Probiotic-derived vesicles rectally delivered via Thermo-gelling copolymer promote mucosal healing and reduce inflammation in ulcerative colitis","volume":"17","author":"Mairal","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/pharmaceutics17040476","article-title":"Role of gut microbiota and metabolomics in predicting response to vedolizumab in inflammatory bowel disease: a systematic review","volume":"17","author":"Malinauskiene","year":"2025","journal-title":"Pharmaceutics"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/nu18091329","article-title":"The assessment of multidimensional clinical, biological and patient-reported outcomes to evaluate the efficacy of add-on Lactobacillus rhamnosus GG supplementation in mild ulcerative colitis: a randomized pilot trial","volume":"18","author":"Maragno","year":"2026","journal-title":"Nutrients"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/MIB.0000000000000084","article-title":"Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis","volume":"20","author":"Mardini","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13318-015-0315-0","article-title":"Effect of Lactobacillus casei on the pharmacokinetics of amiodarone in male Wistar rats","volume":"42","author":"Matuskova","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e87150","DOI":"10.1371\/journal.pone.0087150","article-title":"Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amiodarone absorption in rats","volume":"9","author":"Matuskova","year":"2014","journal-title":"PLoS One"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"2287073","DOI":"10.1080\/19490976.2023.2287073","article-title":"Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review","volume":"15","author":"Meade","year":"2023","journal-title":"Gut Microbes"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","article-title":"Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease","volume":"29","author":"Mehta","year":"2023","journal-title":"Nat. Med."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"e22398","DOI":"10.1096\/fj.202200148RR","article-title":"Intestinal aberrant sphingolipid metabolism shaped-gut microbiome and bile acids metabolome in the development of hepatic steatosis","volume":"36","author":"Miao","year":"2022","journal-title":"FASEB J."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s40262-024-01419-7","article-title":"Pharmacokinetics and pharmacodynamics of systemic corticosteroids in autoimmune and inflammatory diseases: a review of current evidence","volume":"63","author":"M\u00f6hlmann","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.anaerobe.2015.04.007","article-title":"Non-classical azoreductase secretion in Clostridium perfringens in response to sulfonated azo dye exposure","volume":"34","author":"Morrison","year":"2015","journal-title":"Anaerobe"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpb.2022.12.013","article-title":"In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release","volume":"183","author":"Moutaharrik","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"CD000543","DOI":"10.1002\/14651858.CD000543.pub5","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"2020","author":"Murray","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s44395-026-00045-5","article-title":"Pharmacomicrobiomics mechanisms clinical applications and analytical approaches","volume":"2","author":"Neelam","year":"2026","journal-title":"Discov. Pharm. Sci."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.7759\/cureus.1177","article-title":"Crohn\u2019s disease and ulcerative colitis show unique cytokine profiles","volume":"9","author":"Nemeth","year":"2017","journal-title":"Cureus"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41522-025-00663-4","article-title":"Bifidobacterium longum NSP001-derived extracellular vesicles ameliorate ulcerative colitis by modulating T cell responses in gut microbiota-(in)dependent manners","volume":"11","author":"Nie","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1038\/s41598-021-92870-0","article-title":"Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis","volume":"11","author":"Nishihara","year":"2021","journal-title":"Sci. Rep."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1787284","DOI":"10.3389\/fmicb.2026.1787284","article-title":"Probiotics for ulcerative colitis: mechanisms, therapeutic advances, and emerging strategies","volume":"17","author":"Niu","year":"2026","journal-title":"Front. Microbiol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s43856-024-00448-4","article-title":"Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients","volume":"4","author":"Nogimori","year":"2024","journal-title":"Commun. Med."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"102593","DOI":"10.1016\/j.coi.2025.102593","article-title":"Curing inflammatory bowel diseases: breaking the barriers of current therapies\u2013emerging strategies for a definitive treatment","volume":"95","author":"Noviello","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/mrr.2023.41","article-title":"Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches","volume":"2","author":"O\u2019Reilly","year":"2023","journal-title":"Microbiome Res. Rep."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4166\/kjg.2020.0119","article-title":"Therapeutic potential of Escherichia coli Nissle 1917 in clinically remission-attained ulcerative colitis patients: a hospital-based cohort study","volume":"77","author":"Oh","year":"2021","journal-title":"Korean J. Gastroenterol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13099-024-00637-5","article-title":"Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets","volume":"16","author":"Oh","year":"2024","journal-title":"Gut Pathog."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/apt.15227","article-title":"Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis","volume":"49","author":"Olaisen","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"2341670","DOI":"10.1080\/19490976.2024.2341670","article-title":"Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease","volume":"16","author":"Olovo","year":"2024","journal-title":"Gut Microbes"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5507\/bp.2016.044","article-title":"The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study","volume":"160","author":"Palumbo","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ibd\/izae282.015","article-title":"Targeting MYD88-JAK2 signaling in aberrantly differentiated mesenchymal progenitors in ulcerative colitis","volume":"31","author":"Panganiban","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"BSR20180943","DOI":"10.1042\/BSR20180943","article-title":"Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial","volume":"39","author":"Peng","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ibd.21222","article-title":"Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis","volume":"16","author":"Ng","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"114468","DOI":"10.1016\/j.biopha.2023.114468","article-title":"Exploring the potential impact of probiotic use on drug metabolism and efficacy","volume":"161","author":"Purdel","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.apsb.2025.03.008","article-title":"Bacterial extracellular vesicles for gut microbiome-host communication and drug development","volume":"15","author":"Qian","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"2489765","DOI":"10.1080\/19490976.2025.2489765","article-title":"Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseases","volume":"17","author":"Qiao","year":"2025","journal-title":"Gut Microbes"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"2527863","DOI":"10.1080\/19490976.2025.2527863","article-title":"Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohort","volume":"17","author":"Radhakrishnan","year":"2025","journal-title":"Gut Microbes"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jvim.16672","article-title":"Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: a double-blind randomized trial","volume":"37","author":"Rak","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref149","first-page":"8","article-title":"Effect of various Lactobacillus probiotic strains on oral antihypertensive drug response: a systematic review","volume":"10","author":"Ramadhani","year":"2025","journal-title":"Pharmacol. Clin. Pharm. Res."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1002\/jev2.70004","article-title":"Bacterial extracellular vesicles as intranasal postbiotics: detailed characterization and interaction with airway cells","volume":"13","author":"Razim","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"e22636","DOI":"10.7759\/cureus.22636","article-title":"Ulcerative colitis-induced colorectal carcinoma: a deleterious concatenation","volume":"14","author":"Rivera","year":"2022","journal-title":"Cureus"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.gastrohep.2024.01.007","article-title":"Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish working Group on Crohn\u2019s disease and ulcerative colitis","volume":"47","author":"Rodr\u00edguez-Moranta","year":"2024","journal-title":"Gastroenterol. Hepatol."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"101811","DOI":"10.1016\/j.jcmgh.2026.101811","article-title":"Dietary tryptophan enhances aryl hydrocarbon receptor activation and reduces colitis through microbial metabolism","volume":"20","author":"Rondeau","year":"2026","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3389\/fimmu.2019.02754","article-title":"Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease","volume":"10","author":"Russo","year":"2019","journal-title":"Front. Immunol."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1021\/acsabm.5c00959","article-title":"Probiotic bacteria as therapeutics and biohybrid drug carriers: advances, design strategies, and future outlook","volume":"8","author":"Sahoo","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"19186","DOI":"10.1038\/s41598-020-76175-2","article-title":"Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis","volume":"10","author":"Sakurai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"7378-26","DOI":"10.2169\/internalmedicine.7378-26","article-title":"Small molecules as advanced therapy for the treatment of inflammatory bowel disease, particularly regarding ulcerative colitis","author":"Sakurai","year":"2026","journal-title":"Intern. Med."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1177\/0300060518788994","article-title":"Lactobacillus plantarum IS-10506 probiotic administration increases amlodipine absorption in a rabbit model","volume":"46","author":"Saputri","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1487641","DOI":"10.3389\/fmicb.2024.1487641","article-title":"A comprehensive review of probiotics and human health-current prospective and applications","volume":"15","author":"Sarita","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jmb.2003.08.039","article-title":"Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme","volume":"333","author":"Scheuermann","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/cells9102283","article-title":"Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy","volume":"9","author":"Schierov\u00e1","year":"2020","journal-title":"Cells"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3390\/cells10113188","article-title":"Fecal microbiome changes and specific anti-bacterial response in patients with IBD during anti-TNF therapy","volume":"10","author":"Schierov\u00e1","year":"2021","journal-title":"Cells"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"123397","DOI":"10.51894\/001c.123397","article-title":"Current pharmacologic options and emerging therapeutic approaches for the management of ulcerative colitis: a narrative review","volume":"9","author":"Sebastian","year":"2024","journal-title":"Spartan Med. Res. J."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/apt.14334","article-title":"A multi-Centre audit of excess steroid use in 1176 patients with inflammatory bowel disease","volume":"46","author":"Selinger","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"1690279","DOI":"10.3389\/fimmu.2025.1690279","article-title":"The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease","volume":"16","author":"Shen","year":"2025","journal-title":"Front. Immunol."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10147-026-02970-y","article-title":"Statistics and epidemiology of inflammatory bowel disease-associated colorectal neoplasia","volume":"31","author":"Shinagawa","year":"2026","journal-title":"Int. J. Clin. Oncol."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12664-025-01864-7","article-title":"Revisiting thiopurines and therapeutic drug monitoring in IBD: insights and implications in the Indian context","volume":"45","author":"Singh","year":"2026","journal-title":"Indian J. Gastroenterol."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/CEOR.S391413","article-title":"Systematic literature review of real-world evidence on dose escalation and treatment switching in ulcerative colitis","volume":"15","author":"Singh","year":"2023","journal-title":"Clinicoecon. Outcomes Res."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1569348","DOI":"10.3389\/frmbi.2025.1569348","article-title":"Chemistry, manufacturing, and controls for live microbial products: addressing classification challenges and enhancing process validation","volume":"4","author":"Slijkerman","year":"2025","journal-title":"Front. Microbiomes"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"176252","DOI":"10.1016\/j.cej.2026.176252","article-title":"A self-adaptive biomimetic cocoon regulating gut microbiota for enhanced prodrug activation in IBD therapy","volume":"537","author":"Song","year":"2026","journal-title":"Chem. Eng. J."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"1202.e1","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1002\/jps.24103","article-title":"On the colonic bacterial metabolism of azo-bonded prodrugs of 5-aminosalicylic acid","volume":"103","author":"Sousa","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"e70225","DOI":"10.1002\/fft2.70225","article-title":"Indole-3-acetic acid improves intestinal inflammation and intestinal barrier dysfunction in vitro via the AHR\/NF-\u03baB signaling pathway","volume":"7","author":"Sun","year":"2026","journal-title":"Food Front."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ibd.20003","article-title":"Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis","volume":"13","author":"Swidsinski","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.3390\/biomedicines11123144","article-title":"The role of the microbiome in the pathogenesis and treatment of ulcerative colitis\u2013a literature review","volume":"11","author":"\u015awirkosz","year":"2023","journal-title":"Biomedicine"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ibd\/izaf284","article-title":"Combination therapy with fecal microbiota transplantation and vedolizumab for induction of remission in ulcerative colitis: an open-label pilot study","volume":"32","author":"Syed","year":"2026","journal-title":"Inflamm. Bowel Dis."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/ecco-jcc\/jjae084","article-title":"Gut microbial species and endotypes associate with remission in ulcerative colitis patients treated with anti-TNF or anti-integrin therapy","volume":"18","author":"Tamburini","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"ref179","first-page":"8234","article-title":"Effect of mesalazine combined with probiotics on inflammation and immune function of patients with inflammatory bowel disease","volume":"14","author":"Tan","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"1610435","DOI":"10.3389\/fcell.2025.1610435","article-title":"Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine","volume":"13","author":"Tang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"e85923","DOI":"10.7759\/cureus.85923","article-title":"Effect of biologic therapies in treating moderate-to-severe ulcerative colitis: a systematic review and meta-analysis","volume":"17","author":"Thadiboina","year":"2025","journal-title":"Cureus"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"6923609","DOI":"10.1155\/2020\/6923609","article-title":"The efficacy and safety of mesalamine and probiotics in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis","volume":"2020","author":"Tian","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1248\/bpb.b25-00265","article-title":"Effect of probiotics on immunosuppressive drug pharmacokinetics: interaction between Bacillus subtilis and tacrolimus in mice","volume":"48","author":"Tsuchiya","year":"2025","journal-title":"Biol. Pharm. Bull."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1341333","DOI":"10.3389\/fphar.2024.1341333","article-title":"The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status","volume":"15","author":"Vagnerov\u00e1","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molmed.2024.12.005","article-title":"Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects","volume":"31","author":"Vallejos","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejpb.2021.07.014","article-title":"Mesalazine and inflammatory bowel disease\u2013from well-established therapies to progress beyond the state of the art","volume":"167","author":"Veloso","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"eadg8357","DOI":"10.1126\/scitranslmed.adg8357","article-title":"Integrating the gut microbiome and pharmacology","volume":"16","author":"Verdegaal","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"105812","DOI":"10.1016\/j.ejps.2021.105812","article-title":"Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review","volume":"162","author":"Vinarov","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1038\/s41598-023-39491-x","article-title":"5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis","volume":"13","author":"Wada","year":"2023","journal-title":"Sci. Rep."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/sjg.SJG_462_20","article-title":"Clinical effects of ursodeoxycholic acid on patients with ulcerative colitis may improve via the regulation of IL-23-IL-17 axis and the changes of the proportion of intestinal microflora","volume":"27","author":"Wang","year":"2021","journal-title":"Saudi J. Gastroenterol."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjx153","article-title":"Characteristics of faecal microbiota in paediatric Crohn's disease and their dynamic changes during infliximab therapy","volume":"12","author":"Wang","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.2147\/JIR.S432747","article-title":"Indole-3-aldehyde reduces inflammatory responses and restores intestinal epithelial barrier function partially via aryl hydrocarbon receptor (AhR) in experimental colitis models","volume":"16","author":"Wang","year":"","journal-title":"J. Inflamm. Res."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.dmpk.2022.100458","article-title":"Intestinal microbiota-mediated biotransformations alter the pharmacokinetics of the major metabolites of azathioprine in rats after oral administration","volume":"45","author":"Wang","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00210-024-03485-x","article-title":"5-aminosalicylic acid alleviates colitis and protects intestinal barrier function by modulating gut microbiota in mice","volume":"398","author":"Wang","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref195","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13099-023-00540-5","article-title":"Gut microbiota and host cytochrome P450 characteristics in the pseudo germ-free model: co-contributors to a diverse metabolic landscape","volume":"15","author":"Wang","year":"","journal-title":"Gut Pathog."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"388.e6","DOI":"10.1016\/j.medj.2022.04.007","article-title":"Heterogeneity in statin responses explained by variation in the human gut microbiome","volume":"3","author":"Wilmanski","year":"2022","journal-title":"Med."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl. Res."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"902337","DOI":"10.3389\/fphar.2022.902337","article-title":"Bifidobacterium longum CECT 7894 improves the efficacy of infliximab for DSS-induced colitis via regulating the gut microbiota and bile acid metabolism","volume":"13","author":"Xiao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fmicb.2018.01274","article-title":"5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref200","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3748\/wjg.v20.i12.3255","article-title":"Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease","volume":"20","author":"Xu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.3390\/nu17243838","article-title":"Research advances in the impact of probiotic supplementation on ulcerative colitis management","volume":"17","author":"Xu","year":"2025","journal-title":"Nutrients"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"25150","DOI":"10.1021\/acs.jafc.5c08885","article-title":"Postbiotics as an innovative intervention strategy for ulcerative colitis: insights into bioactive components and mechanisms of action","volume":"73","author":"Xue","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref203","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2013.09.007","article-title":"Colonic bacterial metabolism of corticosteroids","volume":"457","author":"Yadav","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref204","doi-asserted-by":"publisher","first-page":"101153","DOI":"10.1016\/j.xcrm.2023.101153","article-title":"Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability","volume":"4","author":"Yan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-025-00395-z","article-title":"Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives","volume":"7","author":"Yang","year":"2026","journal-title":"Mol. Biomed."},{"key":"ref206","doi-asserted-by":"publisher","first-page":"25626","DOI":"10.1038\/s41598-025-10851-z","article-title":"Exploring the health benefits of gut microbiota metabolites on combating ulcerative colitis via network pharmacology, bioinformatics and molecular docking","volume":"15","author":"Yao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref207","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/microbiolres16080168","article-title":"Protective effects of a bifidobacterium-based probiotic mixture on gut inflammation and barrier function","volume":"16","author":"You","year":"2025","journal-title":"Microbiol. Res."},{"key":"ref208","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/toxics10040151","article-title":"Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease","volume":"10","author":"Zakerska-Banaszak","year":"2022","journal-title":"Toxics"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00394-024-03520-w","article-title":"The probiotic Lactobacillus plantarum alleviates colitis by modulating gut microflora to activate PPAR\u03b3 and inhibit MAPKs\/NF-\u03baB","volume":"64","author":"Zang","year":"2024","journal-title":"Eur. J. Nutr."},{"key":"ref210","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1124\/dmd.124.001837","article-title":"Effects of compound probiotics on pharmacokinetics of cytochrome P450 probe drugs in rats","volume":"52","author":"Zhang","year":"","journal-title":"Drug Metab. Dispos."},{"key":"ref211","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","article-title":"The influence of the gut microbiota on the bioavailability of oral drugs","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/pharmaceutics16111394","article-title":"Minimal information for studies of extracellular vesicles (MISEV): ten-year evolution (2014\u20132023)","volume":"16","author":"Zhang","year":"","journal-title":"Pharmaceutics"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1007\/s11427-025-3019-2","article-title":"Microbial bile acid modifications: current understandings, key problems, and future perspectives","volume":"68","author":"Zhang","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"ref214","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","article-title":"Gut microbiota modulates drug pharmacokinetics","volume":"50","author":"Zhang","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"ref215","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"ref216","doi-asserted-by":"publisher","first-page":"102669","DOI":"10.1016\/j.mtbio.2025.102669","article-title":"Probiotic-drug co-delivery system enhances sulfasalazine activation for inflammatory bowel disease therapy","volume":"36","author":"Zhao","year":"2025","journal-title":"Mater. Today Bio."},{"key":"ref217","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"ref218","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref219","doi-asserted-by":"publisher","first-page":"953962","DOI":"10.3389\/fcimb.2022.953962","article-title":"Composition and diverse differences of intestinal microbiota in ulcerative colitis patients","volume":"12","author":"Zhu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref220","doi-asserted-by":"publisher","first-page":"1235656","DOI":"10.3389\/fphys.2023.1235656","article-title":"The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Physiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1944134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:44:38Z","timestamp":1789566278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1944134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":220,"alternative-id":["10.3389\/fmicb.2026.1944134"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1944134","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1944134"}}